1. Design, synthesis and evaluation of MCH receptor 1 antagonists—Part I: Optimization of HTS hits towards an in vivo efficacious tool compound BI 414. Issue 16 (15th August 2015) Authors: Müller, Stephan G.; Heckel, Armin; Kley, Jörg T.; Lehmann, Thorsten; Lustenberger, Philipp; Oost, Thorsten; Roth, Gerald J.; Rudolf, Klaus; Arndt, Kirsten; Lenter, Martin; Lotz, Ralf R.H.; Maier, Gerd-Michael; Markert, Michael; Schindler, Marcus; Stenkamp, Dirk Journal: Bioorganic & medicinal chemistry letters Issue: Volume 25:Issue 16(2015) Page Start: 3264 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Design, synthesis and evaluation of MCH receptor 1 antagonists—Part I: Optimization of HTS hits towards an in vivo efficacious tool compound BI 414. Issue 16 (15th August 2015) Authors: Müller, Stephan G.; Heckel, Armin; Kley, Jörg T.; Lehmann, Thorsten; Lustenberger, Philipp; Oost, Thorsten; Roth, Gerald J.; Rudolf, Klaus; Arndt, Kirsten; Lenter, Martin; Lotz, Ralf R.H.; Maier, Gerd-Michael; Markert, Michael; Schindler, Marcus; Stenkamp, Dirk Journal: Bioorganic & medicinal chemistry letters Issue: Volume 25:Issue 16(2015) Page Start: 3264 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Design, synthesis and evaluation of MCH receptor 1 antagonists—Part II: Optimization of pyridazines toward reduced phospholipidosis and hERG inhibition. Issue 16 (15th August 2015) Authors: Roth, Gerald J.; Heckel, Armin; Kley, Jörg T.; Lehmann, Thorsten; Müller, Stephan G.; Oost, Thorsten; Rudolf, Klaus; Arndt, Kirsten; Budzinski, Ralph; Lenter, Martin; Lotz, Ralf R.H.; Schindler, Marcus; Thomas, Leo; Stenkamp, Dirk Journal: Bioorganic & medicinal chemistry letters Issue: Volume 25:Issue 16(2015) Page Start: 3270 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Design, synthesis and evaluation of MCH receptor 1 antagonists—Part II: Optimization of pyridazines toward reduced phospholipidosis and hERG inhibition. Issue 16 (15th August 2015) Authors: Roth, Gerald J.; Heckel, Armin; Kley, Jörg T.; Lehmann, Thorsten; Müller, Stephan G.; Oost, Thorsten; Rudolf, Klaus; Arndt, Kirsten; Budzinski, Ralph; Lenter, Martin; Lotz, Ralf R.H.; Schindler, Marcus; Thomas, Leo; Stenkamp, Dirk Journal: Bioorganic & medicinal chemistry letters Issue: Volume 25:Issue 16(2015) Page Start: 3270 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Design, synthesis and evaluation of MCH receptor 1 antagonists—Part III: Discovery of pre-clinical development candidate BI 186908. Issue 16 (15th August 2015) Authors: Oost, Thorsten; Heckel, Armin; Kley, Jörg T.; Lehmann, Thorsten; Müller, Stephan; Roth, Gerald J.; Rudolf, Klaus; Arndt, Kirsten; Budzinski, Ralph; Lenter, Martin; Lotz, Ralf R.H.; Maier, Gerd-Michael; Markert, Michael; Thomas, Leo; Stenkamp, Dirk Journal: Bioorganic & medicinal chemistry letters Issue: Volume 25:Issue 16(2015) Page Start: 3275 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Design, synthesis and evaluation of MCH receptor 1 antagonists—Part III: Discovery of pre-clinical development candidate BI 186908. Issue 16 (15th August 2015) Authors: Oost, Thorsten; Heckel, Armin; Kley, Jörg T.; Lehmann, Thorsten; Müller, Stephan; Roth, Gerald J.; Rudolf, Klaus; Arndt, Kirsten; Budzinski, Ralph; Lenter, Martin; Lotz, Ralf R.H.; Maier, Gerd-Michael; Markert, Michael; Thomas, Leo; Stenkamp, Dirk Journal: Bioorganic & medicinal chemistry letters Issue: Volume 25:Issue 16(2015) Page Start: 3275 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗